On April 8, 2025, the 91st China International Medical Equipment Fair (CMEF) was successfully concluded in Shanghai National Convention and Exhibition Center. YZY MED showcased numerous scientific and technological achievements to global customers, which attracted the attention of the audience, industry peers and international clients.
As a leading innovator in the field of molecular diagnosis, pathology and precision medicine in China, YZY MED has made a major debut with integrated CTC isolation and staining machine, FISH probe and related equipment. YZY MED focuses on individualized diagnosis and treatment of major diseases such as cardiovascular disease and tumor. The booth drew the attention of distributors and business partners from various countries, with a steady influx of both established and prospective customers engaging in business negotiations.
The D200 all-in-one circulating tumor cell separation and staining system showcased at this exhibition has drawn considerable attention as a leading solution for real-time cancer monitoring in the field of liquid biopsy. This innovative device employs a marker-independent cell separation technology capable of processing individual samples in less than 10 minutes. It enables precise CTC (Circulating Tumor Cell) subtyping and accurate CTM (Circulating Tumor Microemboli) classification, particularly effective in identifying high-risk metastatic patients with neutrophil-rich CTMs.
Meanwhile, the company has showcased its advanced FISH probe reagents and the fully automated FISH slide processing system F902, which demonstrate outstanding performance in fluorescence in situ hybridization applications. As a non-invasive molecular cytogenetic technique, FISH technology allows direct detection of specific nucleic acid sequences within cells and is widely applied in cancer diagnosis, treatment efficacy monitoring, and prognostic evaluation.
While the exhibition has concluded, the pace of technological innovation at YZY MED will never cease. We look forward to continuing our collaboration with global partners, leveraging technology as our vessel and cooperation as our oar, to jointly address industry challenges and propel healthcare into a new era characterized by greater efficiency, accessibility, and intelligence.
